Charles River Laboratories Hits New 52-Week High of $277.07

Charles River Laboratories International, Inc. has reached a significant milestone by hitting a new 52-week high of USD 277.07 on August 10, 2026. This achievement underscores the company's strong performance over the past year, with a notable increase of 29.13%, outpacing the S&P 500's growth of 21.34% during the same period. As a small-cap company with a market capitalization of USD 7,858 million, Charles River Laboratories operates within the miscellaneous industry. The stock currently has a price-to-earnings (P/E) ratio of 26.00, indicating its valuation relative to earnings. The company maintains a debt-to-equity ratio of 0.62, reflecting a balanced approach to leveraging its capital structure. Additionally, the return on equity stands at 9.58%, showcasing effective management of shareholder equity. With a price-to-book ratio of 2.48 and no dividend yield, Charles River Laboratories continues to demonstrate its position in the market, marking this new high as a noteworthy point in its financial journey.